|
1
|
Villanueva A: Hepatocellular carcinoma. N
Engl J Med. 380:1450–1462. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Marrero JA, Kulik LM, Sirlin CB, Zhu AX,
Finn RS, Abecassis MM, Roberts LR and Heimbach JK: Diagnosis,
staging, and management of hepatocellular carcinoma: 2018 practice
guidance by the American association for the study of liver
diseases. Hepatology. 68:723–750. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ye J, Wu S, Pan S, Huang J and Ge L: Risk
scoring based on expression of long non-coding RNAs can effectively
predict survival in hepatocellular carcinoma patients with or
without fibrosis. Oncol Rep. 43:1451–1466. 2020.PubMed/NCBI
|
|
4
|
Bracken CP, Scott HS and Goodall GJ: A
network-biology perspective of microRNA function and dysfunction in
cancer. Nat Rev Genet. 17:719–732. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Heusschen R, van Gink M, Griffioen AW and
Thijssen VL: MicroRNAs in the tumor endothelium: Novel controls on
the angioregulatory switchboard. Biochim Biophys Acta. 1805:87–96.
2010.PubMed/NCBI
|
|
7
|
Xu WP, Liu JP, Feng JF, Zhu CP, Yang Y,
Zhou WP, Ding J, Huang CK, Cui YL, Ding CH, et al: MiR-541
potentiates the response of human hepatocellular carcinoma to
sorafenib treatment by inhibiting autophagy. Gut. 69:1309–1321.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin J, Shen J, Yue H and Cao Z:
MiRNA-183-5p.1 promotes the migration and invasion of gastric
cancer AGS cells by targeting TPM1. Oncol Rep. 42:2371–2381.
2019.PubMed/NCBI
|
|
9
|
Zhang J, Xu S, Xu J, Li Y, Zhang J, Zhang
J and Lu X: MiR-767-5p inhibits glioma proliferation and metastasis
by targeting SUZ12. Oncol Rep. 42:55–66. 2019.PubMed/NCBI
|
|
10
|
Velazquez-Torres G, Shoshan E, Ivan C,
Huang L, Fuentes-Mattei E, Paret H, Kim SJ, Rodriguez-Aguayo C, Xie
V, Brooks D, et al: A-to-I miR-378a-3p editing can prevent melanoma
progression via regulation of PARVA expression. Nat Commun.
9:4612018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Khella HW, Bakhet M, Allo G, Jewett MA,
Girgis AH, Latif A, Girgis H, Von Both I, Bjarnason GA and Yousef
GM: MiR-192, miR-194 and miR-215: A convergent microRNA network
suppressing tumor progression in renal cell carcinoma.
Carcinogenesis. 34:2231–2239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang W, Qian P, Zhang X, Zhang M, Wang H,
Wu M, Kong X, Tan S, Ding K and Perry JK: Autocrine/paracrine human
growth hormone-stimulated MicroRNA 96-182-183 cluster promotes
epithelial-mesenchymal transition and invasion in breast cancer. J
Biol Chem. 290:13812–13829. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Feng X, Wang Z, Fillmore R and Xi Y:
MiR-200, a new star miRNA in human cancer. Cancer Lett.
344:166–173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Belgardt BF, Ahmed K, Spranger M,
Latreille M, Denzler R, Kondratiuk N, von Meyenn F, Villena FN,
Herrmanns K, Bosco D, et al: The microRNA-200 family regulates
pancreatic beta cell survival in type 2 diabetes. Nat Med.
21:619–627. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim YK, Wee G, Park J, Kim J, Baek D, Kim
JS and Kim VN: TALEN-based knockout library for human microRNAs.
Nat Struct Mol Biol. 20:1458–1464. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang J, Song W, Shen W, Yang X, Sun W, Qu
S, Shang R, Ma B, Pu M, Tao K, et al: MicroRNA-200a suppresses cell
invasion and migration by directly targeting GAB1 in hepatocellular
carcinoma. Oncol Res. 25:1–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Feng J, Wang J, Chen M, Chen G, Wu Z, Ying
L, Zhuo Q, Zhang J and Wang W: MiR-200a suppresses cell growth and
migration by targeting MACC1 and predicts prognosis in
hepatocellular carcinoma. Oncol Rep. 33:713–720. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hou X, Yang L, Jiang X, Liu Z, Li X, Xie
S, Li G and Liu J: Role of microRNA-141-3p in the progression and
metastasis of hepatocellular carcinoma cell. Int J Biol Macromol.
128:331–339. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao Y, Xu Z, Zhou J and Yang H: MiR-141
inhibits proliferation, migration and invasion in human
hepatocellular carcinoma cells by directly downregulating TGFβR1.
Oncol Rep. 42:1656–1666. 2019.PubMed/NCBI
|
|
20
|
Mansini AP, Pisarello MJ, Thelen KM,
Cruz-Reyes M, Peixoto E, Jin S, Howard BN, Trussoni CE, Gajdos GB,
LaRusso NF, et al: MicroRNA (miR)-433 and miR-22 dysregulations
induce histone-deacetylase-6 overexpression and ciliary loss in
cholangiocarcinoma. Hepatology. 68:561–573. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lou G, Dong X, Xia C, Ye B, Yan Q, Wu S,
Yu Y, Liu F, Zheng M, Chen Z and Liu Y: Direct targeting
sperm-associated antigen 9 by miR-141 influences hepatocellular
carcinoma cell growth and metastasis via JNK pathway. J Exp Clin
Cancer Res. 35:142016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng L, Xu M, Xu J, Wu K, Fang Q, Liang
Y, Zhou S, Cen D, Ji L, Han W and Cai X: ELF3 promotes
epithelial-mesenchymal transition by protecting ZEB1 from
miR-141-3p-mediated silencing in hepatocellular carcinoma. Cell
Death Dis. 9:3872018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wu L, Pan C, Wei X, Shi Y, Zheng J, Lin X
and Shi L: lncRNA KRAL reverses 5-fluorouracil resistance in
hepatocellular carcinoma cells by acting as a ceRNA against
miR-141. Cell Commun Signal. 16:472018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin L, Liang H, Wang Y, Yin X, Hu Y, Huang
J, Ren T, Xu H, Zheng L and Chen X: MicroRNA-141 inhibits cell
proliferation and invasion and promotes apoptosis by targeting
hepatocyte nuclear factor-3β in hepatocellular carcinoma cells. BMC
Cancer. 14:8792014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lee H, Kim C, Kang H, Tak H, Ahn S, Yoon
SK, Kuh HJ, Kim W and Lee EK: MicroRNA-200a-3p increases
5-fluorouracil resistance by regulating dual specificity
phosphatase 6 expression. Exp Mol Med. 49:e3272017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Paterson EL, Kazenwadel J, Bert AG,
Khew-Goodall Y, Ruszkiewicz A and Goodall GJ: Down-regulation of
the miRNA-200 family at the invasive front of colorectal cancers
with degraded basement membrane indicates EMT is involved in cancer
progression. Neoplasia. 15:180–191. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gibbons DL, Lin W, Creighton CJ, Rizvi ZH,
Gregory PA, Goodall GJ, Thilaganathan N, Du L, Zhang Y,
Pertsemlidis A and Kurie JM: Contextual extracellular cues promote
tumor cell EMT and metastasis by regulating miR-200 family
expression. Genes Dev. 23:2140–2151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang GL, Sun J, Lu Y, Liu Y, Cao H, Zhang
H and Calin GA: MiR-200 family and cancer: From a meta-analysis
view. Mol Aspects Med. 70:57–71. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cimmino A, Calin GA, Fabbri M, Iorio MV,
Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S and Dono M:
MiR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Villadsen SB, Bramsen JB, Ostenfeld MS,
Wiklund ED, Fristrup N, Gao S, Hansen TB, Jensen TI, Borre M,
Ørntoft TF, et al: The miR-143/-145 cluster regulates plasminogen
activator inhibitor-1 in bladder cancer. Br J Cancer. 106:366–374.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Altuvia Y, Landgraf P, Lithwick G, Elefant
N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T and Margalit H:
Clustering and conservation patterns of human microRNAs. Nucleic
Acids Res. 33:2697–2706. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Michael MZ, OConnor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
35
|
Miklossy G, Hilliard TS and Turkson J:
Therapeutic modulators of STAT signalling for human diseases. Nat
Rev Drug Discov. 12:611–629. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu H and Jove R: The STATs of cancer--new
molecular targets come of age. Nat Rev Cancer. 4:97–105. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhang YS, Xin DE, Wang Z, Song X, Sun Y,
Zou QC, Yue J, Zhang C, Zhang JM, Liu Z, et al: STAT4 activation by
leukemia inhibitory factor confers a therapeutic effect on
intestinal inflammation. EMBO J. 15:e995952019.
|
|
38
|
Zhang L, Xu K, Liu C and Chen J:
Meta-analysis reveals an association between signal transducer and
activator of transcription-4 polymorphism and hepatocellular
carcinoma risk. Hepatol Res. 47:303–311. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Li J, Liang L, Liu Y, Luo Y, Liang X, Luo
D, Feng Z, Dang Y, Yang L and Chen G: Clinicopathological
significance of STAT4 in hepatocellular carcinoma and its effect on
cell growth and apoptosis. Onco Targets Ther. 9:1721–1734.
2016.PubMed/NCBI
|
|
40
|
Zhou Y, Zhong JH, Gong FS and Xiao J:
MiR-141-3p suppresses gastric cancer induced transition of normal
fibroblast and BMSC to cancer-associated fibroblasts via targeting
STAT4. Exp Mol Pathol. 107:85–94. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao L, Ji G, Le X, Luo Z, Wang C, Feng M,
Xu L, Zhang Y, Lau WB, Lau B, et al: An integrated analysis
identifies STAT4 as a key regulator of ovarian cancer metastasis.
Oncogene. 36:3384–3396. 2017. View Article : Google Scholar : PubMed/NCBI
|
